NuVasive Inc NK8-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 03/05/21 CET
51.50quote price arrow down-0.50 (-0.96%)
52 week range
26.60 - 59.50

...

Loading . . .

KEY STATS

  • Open51.50
  • Day High51.50
  • Day Low51.50
  • Prev Close52.00
  • 52 Week High59.50
  • 52 Week High Date06/08/20
  • 52 Week Low26.60
  • 52 Week Low Date03/18/20
  • Market Cap3,227.44M
  • Shares Out51.38M
  • 10 Day Average Volume183.18
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-7.21

RATIOS/PROFITABILITY

  • EPS (TTM)-0.60
  • P/E (TTM)-85.83
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest NuVasive Inc News

There is no recent news for this security.

Latest NK8-FF News From Our Partners

QUOTE FINDER

Profile

MORE
Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal product offering includes a minimally-disruptive surgical platform called Maximum Access Surgery (MAS). The platform includes its software-driven nerve...
Gregory Lucier
Chairman
J. Christopher Barry
Chief Executive Officer
Matthew Harbaugh
Chief Financial Officer
Brent Boucher
Executive Vice President
Massimo Calafiore
Executive Vice President
Address
7475 Lusk Blvd
San Diego, CA
92121-5707
United States